Načítá se...
Lessons in precision oncology from neoadjuvant endocrine therapy trials in ER+ breast cancer
For post-menopausal women with clinical stage II/III estrogen receptor positive (ER+) breast cancer neoadjuvant endocrine therapy (NET) is an under-utilized and low-toxicity alternative to chemotherapy for increasing breast conservation rates. Individual responses to endocrine therapy can also be us...
Uloženo v:
| Vydáno v: | Breast |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5592154/ https://ncbi.nlm.nih.gov/pubmed/28669712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2017.06.039 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|